/PRNewswire/ The U.S. Food and Drug Administration has placed a purchase order (75F40123P00369) committing to an annual subscription of digiM I2S, a fully.
DigiM Solution LLC, a technology leader in microstructure analysis, has received a broad agency award (BAA) from the U.S. Food and Drug Administration (FDA).